Fixed ratio versus goal-directed therapy in trauma

Current Opinion in Anaesthesiology

Volumn 29, Issue 2, 2016, Pages 234-244

  Schochl, Herbert ^a,b   Maegele, Marc ^c   Voelckel, Wolfgang ^a  

^a LUDWIG BOLTZMANN INSTITUTE FOR EXPERIMENTAL AND CLINICAL TRAUMATOLOGY   (Austria)

^b AUVA Trauma Centre   (Austria)

^c UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

goal directed coagulation therapy; ratio driven coagulation therapy; trauma induced coagulopathy; viscoelastic tests

Indexed keywords

ANTIFIBRINOLYTIC AGENT; BLOOD CLOTTING FACTOR CONCENTRATE; FIBRINOGEN; THROMBIN; THROMBOCYTE CONCENTRATE; BLOOD CLOTTING FACTOR; HEMOSTATIC AGENT;

ARTICLE; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; BLOOD STORAGE; CRYOPRECIPITATE; ERYTHROCYTE TRANSFUSION; FIBRIN POLYMERIZATION; FIBRINOLYSIS; FIXED RATIO COAGULATION THERAPY; FLUID THERAPY; GOAL DIRECTED COAGULATION THERAPY; HEMOSTASIS; HUMAN; INJURY; INTERNATIONAL NORMALIZED RATIO; PARTIAL THROMBOPLASTIN TIME; PLASMA TRANSFUSION; PRIORITY JOURNAL; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESUSCITATION; SYSTEMATIC REVIEW (TOPIC); THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTE TRANSFUSION; VISCOELASTICITY; COMPLICATION; CYTOLOGY; EMERGENCY HEALTH SERVICE; EUROPE; HEMORRHAGE; PLASMA; POINT OF CARE SYSTEM; PROCEDURES; WOUNDS AND INJURIES;

BLOOD COAGULATION FACTORS; BLOOD COAGULATION TESTS; ERYTHROCYTE TRANSFUSION; EUROPE; HEMORRHAGE; HEMOSTASIS; HEMOSTATICS; HUMANS; PLASMA; PLATELET TRANSFUSION; POINT-OF-CARE SYSTEMS; TRAUMA CENTERS; WOUNDS AND INJURIES;

EID: 84961210679     PISSN: 09527907     EISSN: 14736500     Source Type: Journal    
DOI: 10.1097/ACO.0000000000000278     Document Type: Article

References (91)

1. Teixeira PGR, Inaba K, Hadjizacharia P, et al. Preventable or potentially preventable mortality at a mature trauma center. J Trauma 2007; 63:1338-1347.
2. Kauvar DS, Lefering R, Wade CE. Impact of hemorrhage on trauma outcome: An overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma 2006; 60:S3-S11.
3. Holcomb JB, del Junco DJ, Fox EE, et al. The Prospective, Observational, Multicenter, Major Trauma Transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks. JAMA Surg 2013; 148:127.
4. Mitra B, OReilly G, Cameron PA, et al. Effectiveness of massive transfusion protocols on mortality in trauma: A systematic review and meta-Analysis. ANZ J Surg 2013; 83:918-923.
5. Gregory JA, Huitron SS, George AA, Simon CD. Optimizing transfusion ratios in massive transfusion protocols: An argument against the 1:1:1 dogma and approach to trauma resuscitation. Lab Med 2015; 46:e46-e52.
6. Holcomb JB, Tilley BC, Baraniuk S, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma. JAMA 2015; 313:471.
7. David JS, Godier A, Dargaud Y, Inaba K. Case scenario: management of trauma-induced coagulopathy in a severe blunt trauma patient. Anesthesiology 2013; 119:191-200.
8. Theusinger OM, Madjdpour C, Spahn DR. Resuscitation and transfusion management in trauma patients. Curr Opin Crit Care 2012; 18:661-670.
9. Ziegler B, Schimke C, Marchet P, et al. Severe pediatric blunt trauma: successful ROTEM-guided hemostatic therapy with fibrinogen concentrate and no administration of fresh frozen plasma or platelets. Clin Appl Thromb Hemost 2012; 19:453-459.
10. Schlimp CJ, Voelckel W, Inaba K, et al. Impact of fibrinogen concentrate alone or with prothrombin complex concentrate (+/ fresh frozen plasma) on plasma fibrinogen level and fibrin-based clot strength (FIBTEM) in major trauma: A retrospective study. Scand J Trauma Resusc Emerg Med 2013; 21:74.
11. Grassetto A, De Nardin M, Ganzerla B, et al. ROTEM(R)-guided coagulation factor concentrate therapy in trauma: 2-year experience in Venice, Italy. Crit Care 2012; 16 (3):428.
12. Durila M, Malošek M. Rotational thromboelastometry along with thromboelastography plays a critical role in the management of traumatic bleeding. Am J Emerg Med 2014; 32:288e1-288e3.
13. del Junco DJ, Holcomb JB, Fox EE, et al. Resuscitate early with plasma and platelets or balance blood products gradually. J Trauma Acute Care Surg 2013; 75:S24-S30.
14. Tien H, Beckett A, Garraway N, et al. Advances in damage control resuscitation and surgery: implications on the organization of future military field forces. Can J Surg 2015; 58 (3 Suppl 3):S91-S97.
15. Pohlman TH, Walsh M, Aversa J, et al. Damage control resuscitation. Blood Rev 2015; 29:251-262.
16. Pidcoke HF, Aden JK, Mora AG, et al. Ten-year analysis of transfusion in Operation Iraqi Freedom and Operation Enduring Freedom. J Trauma Acute Care Surg 2012; 73:S445-S452.
17. Johansson PI, Sørensen AM, Larsen CF, et al. Low hemorrhage-related mortality in trauma patients in a Level I trauma center employing transfusion packages and early thromboelastography-directed hemostatic resuscitation with plasma and platelets. Transfusion 2013; 53:3088-3099.
18. Cotton BA, Au BK, Nunez TC, et al. Predefined massive transfusion protocols are associated with a reduction in organ failure and postinjury complications. J Trauma 2009; 66:41-49.
19. Holcomb JB, Wade CE, Michalek JE, et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg 2008; 248:447-458.
20. del Junco DJ, Holcomb JB, Fox EE, et al. Resuscitate early with plasma and platelets or balance blood products gradually: findings from the PROMMTT study. J Trauma Acute Care Surg 2013; 75 (1 Suppl 1):S24-30.
21. Solomon C, Traintinger S, Ziegler B, et al. Platelet function following trauma. A multiple electrode aggregometry study. Thromb Haemost 2011; 106:322-330.
22. Kutcher ME, Redick BJ, McCreery RC, et al. Characterization of platelet dysfunction after trauma. J Trauma Acute Care Surg 2012; 73:13-19.
23. Windeløv NA, Sørensen AM, Perner A, et al. Platelet aggregation following trauma. Blood Coagul Fibrinolysis 2014; 25:67-73.
24. Scott E, Puca K, Heraly J, et al. Evaluation and comparison of coagulation factor activity in fresh-frozen plasma and 24-hour plasma at thaw and after 120 hours of 1 to 6 degrees C storage. Transfusion 2009; 49:1584-1591.
25. Kozar RA, Peng Z, Zhang R, et al. Plasma restoration of endothelial glycocalyx in a rodent model of hemorrhagic shock. Anesth Anal 2011; 112:1289-1295.
26. Ostrowski SR, Johansson PI. Endothelial glycocalyx degradation induces endogenous heparinization in patients with severe injury and early traumatic coagulopathy. J Trauma Acute Care Surg 2012; 73:60-66.
27. Sambasivan CN, Kunio NR, Nair PV, et al. High ratios of plasma and platelets to packed red blood cells do not affect mortality in nonmassively transfused patients. J Trauma 2011; 71:S329-S336.
28. Inaba K, Branco BC, Rhee P, et al. Impact of plasma transfusion in trauma patients who do not require massive transfusion. J Am Coll Surg 2010; 210:957-965.
29. Chhibber V, Greene M, Vauthrin M, et al. Is group A thawed plasma suitable as the first option for emergency release transfusion? (CME). Transfusion 2014; 54:1751-1755.
30. Cardigan R, Green L. Thawed and liquid plasma: what do we know? Vox Sang 2015; 109:1-10.
31. Stubbs JR, Zielinski MD, Berns KS, et al. How we provide thawed plasma for trauma patients. Transfusion 2015; 55:1830-1837.
32. Nascimento B, Callum J, Tien H, et al. Effect of a fixed-ratio (1:1:1) transfusion protocol versus laboratory-results-guided transfusion in patients with severe trauma: A randomized feasibility trial. CMAJ 2013; 185:E583-E589.
33. Glassberg E, Nadler R, Gendler S, et al. Freeze-dried plasma at the point of injury: from concept to doctrine. Shock 2013; 40:444-450.
34. Ponschab M, Schöchl H, Gabriel C, et al. Haemostatic profile of reconstituted blood in a proposed 1:1:1 ratio of packed red blood cells, platelet concentrate and four different plasma preparations. Anaesthesia 2015; 70:528-536.
35. Khan S, Brohi K, Chana M, et al. Hemostatic resuscitation is neither hemostatic nor resuscitative in trauma hemorrhage. J Trauma Acute Care Surg 2014; 76:561-568.
36. Khan S, Davenport R, Raza I, et al. Damage control resuscitation using blood component therapy in standard doses has a limited effect on coagulopathy during trauma hemorrhage. Intens Care Med 2014; 41:239-247.
37. Hallet J, Lauzier F, Mailloux O, et al. The use of higher platelet: RBC transfusion ratio in the acute phase of trauma resuscitation: A systematic review. Crit Care Med 2013; 41 (12):2800-2811.
38. Ponschab M, Schlimp CJ, Zipperle J. Platelet function in reconstituted whole blood variants: An observational study over 5 days of storage time. J Trauma Acute Care Surg 2015; 79:797-804.
39. Peerschke EIB, Castellone DD, Stroobants AK, Francis J. Reference range determination for whole-blood platelet aggregation using the multiplate analyzer. Am J Clin Pathol 2014; 142:647-656.
40. Reddoch KM, Pidcoke HF, Montgomery RK, et al. Hemostatic function of apheresis platelets stored at 48C and 228C. Shock 2014; 41:54-61.
41. Ho AMH, Dion PW, Yeung JHH, et al. Prevalence of survivor bias in observational studies on fresh frozen plasma. Anesthesiology 2012; 116:716-728.
42. Cap A, Hunt BJ. The pathogenesis of traumatic coagulopathy. Anaesthesia 2014; 70:96-101.
43. Haas T, Fries D, Tanaka KA, et al. Usefulness of standard plasma coagulation tests in the management of perioperative coagulopathic bleeding: is there any evidence? Br J Anaesth 2014; 114:217-224.
44. Inaba K, Rizoli S, Veigas PV, et al. 2014 Consensus conference on viscoelastic test-based transfusion guidelines for early trauma resuscitation. J Trauma Acute Care Surg 2015; 78:1220-1229.
45. Schöchl H, Voelckel W, Grassetto A, Schlimp CJ. Practical application of point-of-care coagulation testing to guide treatment decisions in trauma. J Trauma Acute Care Surg 2013; 74:1587-1598.
46. Holcomb JB, Minei KM, Scerbo ML, et al. Admission rapid thrombelastography can replace conventional coagulation tests in the emergency department. Ann Surg 2012; 256:476-486.
47. Stensballe J, Ostrowski SR, Johansson PI. Viscoelastic guidance of resuscitation. Curr Opin Anaesthesiol 2014; 27:212-218.
48. Schochl H, Cotton B, Inaba K, et al. FIBTEM provides early prediction of massive transfusion in trauma. Crit Care 2011; 15:R265.
49. Brohi K, Cohen MJ, Ganter MT, et al. Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway? Ann Surg 2007; 245:812-818.
50. Takahashi H, Tatewaki W, Wada K, et al. Fibrinolysis and fibrinogenolysis in disseminated intravascular coagulation. Thromb Haemost 1990; 63:340-344.
51. Pasche B, Ouimet H, Francis S, Loscalzo J. Structural changes in platelet glycoprotein IIb/IIIa by plasmin: determinants and functional consequences. Blood 1994; 83:404-414.
52. Schöchl H, Frietsch T, Pavelka M, Jámbor C. Hyperfibrinolysis after major trauma: differential diagnosis of lysis patterns and prognostic value of thrombelastometry. J Trauma 2009; 67:125-131.
53. Theusinger OM, Wanner GA, Emmert MY, et al. Hyperfibrinolysis diagnosed by rotational thromboelastometry (rotem1) is associated with higher mortality in patients with severe trauma. Anesth Analg 2011; 113:1003-1012.
54. Ives C, Inaba K, Branco BC, et al. Hyperfibrinolysis elicited via thromboelastography predicts mortality in trauma. J Am Coll Surg 2012; 215:496-502.
55. Chapman MP, Moore EE, Ramos CR, et al. Fibrinolysis greater than 3% is the critical value for initiation of antifibrinolytic therapy. J Trauma Acute Care Surg 2013; 75:961-967.
56. Cotton BA, Harvin JA, Kostousouv V, et al. Hyperfibrinolysis at admission is an uncommon but highly lethal event associated with shock and prehospital fluid administration. J Trauma Acute Care Surg 2012; 73:365-370.
57. Shakur H, Roberts I, Bautista R, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): A randomised, placebo-controlled trial. Lancet 2010; 376:23-32.
58. Harvin JA, Peirce CA, Mims MM, et al. The impact of tranexamic acid on mortality in injured patients with hyperfibrinolysis. J Trauma Acute Care Surg 2015; 78:905-911.
59. Schochl H, Voelckel W, Schlimp CJ. Management of traumatic haemorrhage: The European perspective. Anaesthesia 2015; 70 (Suppl 1):102-107.
60. Schöchl H, Solomon C, Traintinger S, et al. Thromboelastometric (ROTEM) findings in patients suffering from isolated severe traumatic brain injury. J Neurotrauma 2011; 28:2033-2041.
61. Cotton BA, Faz G, Hatch QM, et al. Rapid thrombelastography delivers realtime results that predict transfusion within 1 hour of admission. J Trauma 2011; 71:407-417.
62. Leemann H, Lustenberger T, Talving P, et al. The role of rotation thromboelastometry in early prediction of massive transfusion. J Trauma 2010; 69:1403-1409.
63. Tauber H, Innerhofer P, Breitkopf R, et al. Prevalence and impact of abnormal ROTEM(R) assays in severe blunt trauma: results of the Diagnosis and Treatment of Trauma-Induced Coagulopathy (DIA-TRE-TIC) study. Br J Anaesth 2011; 107:378-387.
64. Davenport R, Manson J, DeAth H, et al. Functional definition and characterization of acute traumatic coagulopathy. Crit Care Med 2011; 39:2652-2658.
65. Meyer ASP, Meyer MAS, Sørensen AM, et al. Thrombelastography and rotational thromboelastometry early amplitudes in 182 trauma patients with clinical suspicion of severe injury. J Trauma Acute Care Surg 2014; 76:682-690.
66. Schlimp CJ, Solomon C, Ranucci M, et al. The effectiveness of different functional fibrinogen polymerization assays in eliminating platelet contribution to clot strength in thromboelastometry. Anesth Analg 2014; 118:269-276.
67. Schlimp CJ, Voelckel W, Inaba K, et al. Estimation of plasma fibrinogen levels based on hemoglobin, base excess and Injury Severity Score upon emergency room admission. Crit Care 2013; 17:R137.
68. Floccard B, Rugeri L, Faure A, et al. Early coagulopathy in trauma patients: An on-scene and hospital admission study. Injury 2012; 43:26-32.
69. Rourke C, Curry N, Khan S, et al. Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost 2012; 10:1342-1351.
70. Hagemo JS, Stanworth S, Juffermans NP, et al. Prevalence, predictors and outcome of hypofibrinogenaemia in trauma: A multicentre observational study. Crit Care 2014; 18:R52.
71. Inaba K, Karamanos E, Lustenberger T, et al. Impact of fibrinogen levels on outcomes after acute injury in patients requiring a massive transfusion. J Am Coll Surg 2013; 216:290-297.
72. Gando S, Ono Y, Wada T, et al. Fibrinogen level deteriorates before other routine coagulation parameters and massive transfusion in the early phase of severe trauma: A retrospective observational study. Semin Thromb Hemost 2015; 41:035-042.
73. Schöchl H, Schlimp CJ, Voelckel W. Potential value of pharmacological protocols in trauma. Curr Opin Anaesthesiol 2013; 26:221-229.
74. Spahn DR, Bouillon B, Cerny V, et al. Management of bleeding and coagulopathy following major trauma: An updated European guideline. Crit Care 2013; 17:R76.
75. Chambers LA, Chow SJ. And LET Shaffer. Frequency and characteristics of coagulopathy in trauma patients treated with a low-or high-plasma-content massive transfusion protocol. Am J Clin Pathol 2011; 136:364-370.
76. Collins PW, Solomon C, Sutor K, et al. Theoretical modelling of fibrinogen supplementation with therapeutic plasma, cryoprecipitate, or fibrinogen concentrate. Br J Anaesth 2014; 113:585-595.
77. Solomon C, Ranucci M, Hochleitner G, et al. Assessing the methodology for calculating platelet contribution to clot strength (platelet component) in thromboelastometry and thrombelastography. Anesth Analg 2015; 121:868-878.
78. Ponschab M, Voelckel W, Pavelka M, et al. Effect of coagulation factor concentrate administration on ROTEM1 parameters in major trauma. Scand J Trauma Resus Emerg Med 2015; 23:84.
79. Lang T, Johanning K, Metzler H, et al. The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia. Anesth Analg 2009; 108:751-758.
80. Mann KG, Brummel K, Butenas S. What is all that thrombin for? J Thromb Haemost 2003; 1:1504-1514.
81. Cardenas JC, Rahbar E, Pommerening MJ, et al. Measuring thrombin generation as a tool for predicting hemostatic potential and transfusion requirements following trauma. J Trauma Acute Care Surg 2014; 77:839-845.
82. Dunbar NM, Chandler WL. Transfusion practice: Thrombin generation in trauma patients. Transfusion 2009; 49:2652-2660.
83. Honickel M, Rieg A, Rossaint R, et al. Prothrombin complex concentrate reduces blood loss and enhances thrombin generation in a pig model with blunt liver injury under severe hypothermia. Thromb Haemost 2011; 106:724-733.
84. Weiss G, Lison S, Spannagl M, Heindl B. Expressiveness of global coagulation parameters in dilutional coagulopathy. Br J Anaesth 2010; 105:429-436.
85. Schöchl H, Nienaber U, Maegele M, et al. Transfusion in trauma: Thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care 2011; 15:R83.
86. Hunt H, Hyde C, Stanworth S, et al. Thromboelastography (TEG) and thromboelastometry (ROTEM) for trauma-induced coagulopathy in adult trauma patients with bleeding. Cochrane Database Syst Rev 2015; 2:CD010438.
87. Schöchl H, Nienaber U, Hofer G, et al. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM1)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 2010; 14:R55.
88. Tapia NM, Chang A, Norman M, et al. TEG-guided resuscitation is superior to standardized MTP resuscitation in massively transfused penetrating trauma patients. J Trauma Acute Care Surg 2013; 74:378-386.
89. Yin J, Zhao Z, Li Y, et al. Goal-directed transfusion protocol via thrombelastography in patients with abdominal trauma: A retrospective study. World J Emerg Surg 2014; 9:28.
90. Johansson PI. Goal-directed hemostatic resuscitation for massively bleeding patients: The Copenhagen concept. Transfus Apher Sci 2010; 43:401-405.
91. Nardi G, Agostini V, Rondinelli B, et al. Trauma-induced coagulopathy: impact of the early coagulation support protocol on blood product consumption, mortality and costs. Crit Care 2015; 19:83.